| scholarly article | Q13442814 |
| P2093 | author name string | Michael E Pichichero | |
| Ravinder Kaur | |||
| Naveen Surendran | |||
| Martina Ochs | |||
| P2860 | cites work | Randomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02V in elderly adults | Q33601853 |
| Solution structure of choline binding protein A, the major adhesin of Streptococcus pneumoniae | Q33739670 | ||
| The autolytic enzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin | Q33996189 | ||
| The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia | Q34002787 | ||
| Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis | Q34005995 | ||
| Differential protein expression in phenotypic variants of Streptococcus pneumoniae | Q34007754 | ||
| Serotype replacement in disease after pneumococcal vaccination | Q34178363 | ||
| Mn2+-dependent regulation of multiple genes in Streptococcus pneumoniae through PsaR and the resultant impact on virulence | Q34334220 | ||
| Density and duration of pneumococcal carriage is maintained by transforming growth factor β1 and T regulatory cells | Q34479487 | ||
| Preclinical Evaluation of the Pht Proteins as Potential Cross-Protective Pneumococcal Vaccine Antigens | Q34484575 | ||
| Pneumolysin in pneumococcal adherence and colonization | Q34488348 | ||
| Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae | Q34549615 | ||
| Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies | Q34779050 | ||
| Pneumolysin: a double-edged sword during the host-pathogen interaction | Q34824489 | ||
| Nasopharyngeal antibodies to pneumococcal pneumolysin in children with acute otitis media | Q35225029 | ||
| Uptake of Streptococcus pneumoniae by respiratory epithelial cells | Q35518668 | ||
| Co-colonization by Haemophilus influenzae with Streptococcus pneumoniae enhances pneumococcal-specific antibody response in young children | Q35531214 | ||
| Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae | Q35532255 | ||
| Streptococcus pneumoniae colonisation: the key to pneumococcal disease | Q35681330 | ||
| Pneumolysin, PspA, and PspC contribute to pneumococcal evasion of early innate immune responses during bacteremia in mice | Q35783747 | ||
| Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone children | Q35811715 | ||
| Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury | Q36018158 | ||
| Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans | Q36376010 | ||
| Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies | Q36558990 | ||
| Antibody response to Streptococcus pneumoniae proteins PhtD, LytB, PcpA, PhtE and Ply after nasopharyngeal colonization and acute otitis media in children | Q36920037 | ||
| Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin | Q37105935 | ||
| The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease | Q37109940 | ||
| Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms | Q37174555 | ||
| Antibodies to pneumococcal proteins PhtD, CbpA, and LytC in Filipino pregnant women and their infants in relation to pneumococcal carriage | Q37213916 | ||
| Surface association of Pht proteins of Streptococcus pneumoniae. | Q37264619 | ||
| Pneumococcal surface adhesin A (PsaA): a review | Q37279975 | ||
| A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae | Q37333825 | ||
| Maternal antibodies to pneumolysin but not to pneumococcal surface protein A delay early pneumococcal carriage in high-risk Papua New Guinean infants | Q37410062 | ||
| Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors | Q37459576 | ||
| Role of Pht proteins in attachment of Streptococcus pneumoniae to respiratory epithelial cells | Q37713234 | ||
| Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults | Q38058158 | ||
| Current status and perspectives on protein-based pneumococcal vaccines | Q38124921 | ||
| Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis | Q39023214 | ||
| PcpA of Streptococcus pneumoniae mediates adherence to nasopharyngeal and lung epithelial cells and elicits functional antibodies in humans | Q39314657 | ||
| Relationship between phase variation in colony morphology, intrastrain variation in cell wall physiology, and nasopharyngeal colonization by Streptococcus pneumoniae. | Q39825198 | ||
| Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins | Q40619089 | ||
| Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae | Q41080026 | ||
| Export requirements of pneumolysin in Streptococcus pneumoniae. | Q42182834 | ||
| Molecular characterization of PcpA: a novel choline-binding protein of Streptococcus pneumoniae | Q42681508 | ||
| Structure-guided antigen engineering yields pneumolysin mutants suitable for vaccination against pneumococcal disease | Q42708867 | ||
| Early predictors of mortality in pneumococcal bacteraemia | Q43801991 | ||
| Pneumococcal histidine triad proteins are regulated by the Zn2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H. | Q46275942 | ||
| Biochemical Characterization of the Histidine Triad Protein PhtD as a Cell Surface Zinc-Binding Protein of Pneumococcus | Q57242796 | ||
| Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein | Q67816410 | ||
| Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo | Q67903731 | ||
| Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae | Q74184782 | ||
| Otitis media | Q86354303 | ||
| Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model | Q87680192 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| Streptococcus pneumoniae | Q221179 | ||
| P304 | page(s) | 5069-5075 | |
| P577 | publication date | 2014-09-22 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Human antibodies to PhtD, PcpA, and Ply reduce adherence to human lung epithelial cells and murine nasopharyngeal colonization by Streptococcus pneumoniae | |
| P478 | volume | 82 |
| Q37473239 | A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge |
| Q47602559 | Beyond binding: antibody effector functions in infectious diseases. |
| Q90461757 | Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection |
| Q47658958 | Development of pneumococcal vaccines over the last 10 years |
| Q38378380 | Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study. |
| Q90820622 | Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study |
| Q40254569 | Epigallocatechin gallate inhibits Streptococcus pneumoniae virulence by simultaneously targeting pneumolysin and sortase A. |
| Q38795815 | Immunization with LytB protein of Streptococcus pneumoniae activates complement-mediated phagocytosis and induces protection against pneumonia and sepsis |
| Q52365761 | Immunodominance in T cell responses elicited against different domains of detoxified pneumolysin PlyD1. |
| Q35624139 | In vitro biofilm development of Streptococcus pneumoniae and formation of choline-binding protein-DNA complexes |
| Q37625776 | Insights into structure and activity of natural compound inhibitors of pneumolysin |
| Q40234319 | Juglone alleviates pneumolysin-induced human alveolar epithelial cell injury via inhibiting the hemolytic activity of pneumolysin |
| Q53269550 | Liposomes as novel anti-infectives targeting bacterial virulence factors? |
| Q37130191 | Next generation protein based Streptococcus pneumoniae vaccines |
| Q64229705 | Novel Protein-Based Pneumococcal Vaccines: Assessing the Use of Distinct Protein Fragments Instead of Full-Length Proteins as Vaccine Antigens |
| Q97883476 | Pneumolysin: Pathogenesis and Therapeutic Target |
| Q90284439 | Prevalence of Various Vaccine Candidate Proteins in Clinical Isolates of Streptococcus pneumoniae: Characterization of the Novel Pht Fusion Proteins PhtA/B and PhtA/D |
| Q37309218 | Rationale and prospects for novel pneumococcal vaccines |
Search more.